CNMD vs TXT · P/E 19, rev $1.37B vs P/E 19, rev $7.52B
CONMED Corporation (CNMD) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported CNMD revenue for 2025-12-31 was $1.37B. Net income was $47.1M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the CNMD and TXT stock pages for the full models.
Not investment advice.